A QUANTITATIVE-ANALYSIS OF THE GLOMERULI IN FOCAL SEGMENTAL GLOMERULOSCLEROSIS

被引:16
作者
SUZUKI, J [1 ]
YOSHIKAWA, N [1 ]
NAKAMURA, H [1 ]
机构
[1] KOBE UNIV HOSP,DEPT PAEDIAT,CHUO KU,KOBE 650,JAPAN
关键词
FOCAL SEGMENTAL GLOMERULOSCLEROSIS; MINIMAL CHANGE NEPHROTIC SYNDROME; MESANGIAL MATRIX INCREASE; GLOMERULAR HYPERTROPHY; NEPHROTIC SYNDROME;
D O I
10.1007/BF00856517
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Quantitative analysis of the glomerular area, mesangial matrix and mesangial cells was performed using renal biopsy specimens from 22 children with focal segmental glomerulosclerosis (FSGS) and 20 with minimal change nephrotic syndrome (MCNS). Non-sclerotic glomeruli were examined. All children in both groups showed nephrotic syndrome at the time of biopsy. Children with benign haematuria were examined as controls. Glomerular area increased with age in the FSGS, MCNS and control groups. The glomerular area was significantly greater in FSGS (1.5+/-0.4x10(4) mu m(2)) than in MCNS (1.2+/-0.2x 10(4) mu m(2)) or in controls (1.2+/-0.3x10(4) mu m(2)) (P < 0.05). Mesangial matrix was increased with age in the three groups. The mesangial matrix was significantly increased in FSGS (28.3+/-4.0%; mesangial matrix area/glomerular area) compared with MCNS (24.9+/-4.1%) and controls (23.0+/-3.0%) (P < 0.01). These findings suggest that both glomerular hypertrophy and mesangial matrix increase in non-sclerotic glomeruli in FSGS may lead to glomerular sclerosis.
引用
收藏
页码:416 / 419
页数:4
相关论文
共 24 条
  • [1] Yoshikawa N., Cameron A.H., White P.H.R., Ultrastructure of the non-sclerotic glomeruli in childhood nephrotic syndrome, J Pathol, 136, pp. 133-147, (1982)
  • [2] Yoshikawa N., Ito H., Akamatsu R., Matsuyama S., Hasegawa O., Nakamura C., Matsuo T., Focal segmental glomerulo-sclerosis with and without nephrotic syndrome, J Pediatr, 109, pp. 65-70, (1986)
  • [3] Doi T., Streiker L.J., Quaife C., Conti F.G., Ralmiter R., Behringer R., Brinster R., Striker G., Progressive glomerulosclerosis develops in transgenic mice chronically expressing growth hormone and growth hormone releasing factor but not in those expressing insulin-like growth factor-1, Am J Pathol, 131, pp. 398-403, (1988)
  • [4] MacKay K., Striker L.J., Stauffer J.W., Relationship of glomerular hypertrophy and sclerosis: studies in SV40 transgenic mice, Kidney Int, 37, pp. 741-748, (1990)
  • [5] Grond J., Koudstaal J., Elema J.D., Mesangial function and glomerular sclerosis in rats with aminonucleoside nephrosis, Kidney Int, 27, pp. 404-410, (1985)
  • [6] Keane W.F., Rau L., Relationship among altered glomerular barrier permselectivity, angiotensin II and mesangial uptake of macromolecules, Lab Invest, 52, pp. 599-604, (1985)
  • [7] Churg J., Habib R., White R.H.R., Pathology of the nephrotic syndrome in children. A report for the International Study of Kidney Disease in Children, Lancet, 1, pp. 1299-1302, (1970)
  • [8] Yoshikawa N., Uehara S., Yamada K., Ikeuchi H., Hiraumi M., Matsuo T., Okada S., Clinicopathological study of persistent asymptomatic proteinuria in children, Nephron, 25, pp. 127-133, (1980)
  • [9] Suzuki J., Yoshikawa N., Nakamura H., A quantitative analysis of the mesangium in children with IgA nephropathy: sequential study, J Pathol, 161, pp. 57-64, (1990)
  • [10] Teodoru C.V., Salfer A., Frankel H., Conditioning factors influencing evolution of experimental glomerulonephritis in rabbits, Am J Physiol, 196, pp. 457-460, (1959)